Page 50 - ILAE_Lectures_2015

15. Mullen SA, Carvill GL, Bellows S et al. Copy number variants are frequent in genetic generalized epilepsy with
intellectual disability. Neurology 2013;81(17):1507-14.

16. Epi4K Consortium, EpilepsyPhenome/Genome Project, Allen AS et al. De novo mutations in epileptic
encephalopathies. Nature 2013;501:217-21.

17. EuroEPINOMICS-RES Consortium, EpilepsyPhenome/Genome Project, Epi4K Consortium et al. De novo
mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet
2014;95(4):360-70.

18. Simons C, Griffin LB, Helman G et al. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-
recessive early-onset epileptic encephalopathy with persistent myelination defect. Am J Hum Genet
2015;96(4):675-81.

19. Syrbe S, Hedrich UB, Riesch E et al. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic
encephalopathy. Nat Genet 2015;47(4):393-9.

20. Schubert J, Siekierska A, Langlois M et al. Mutations in STX1B, encoding a presynaptic protein, cause fever-
associated epilepsy syndromes. Nat Genet. 2014;46(12):1327-32.

21. Lalani SR, Zhang J, Schaaf CP et al. Mutations in PURA cause profound neonatal hypotonia, seizures, and
encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet 2014;95(5):579-83.

22. Mignot C, Lambert L, Pasquier L et al. WWOX-related encephalopathies: delineation of the phenotypical
spectrum and emerging genotype-phenotype correlation. J Med Genet 2015;52(1):61-70.

23. Thevenon J, Milh M, Feillet F et al. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy
with seizure onset in the first days of life. Am J Hum Genet 2014;95(1):113-20.

24. Perrault I, Hamdan FF, Rio M et al. Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical
blindness. Am J Hum Genet 2014;94(6):891-7.

25. Basel-Vanagaite L, Hershkovitz T, Heyman E et al. Biallelic SZT2 mutations cause infantile encephalopathy with
epilepsy and dysmorphic corpus callosum. Am J Hum Genet 2013;93(3):524-9.

26. Hammond P, McKee S, Suttie M et al. Opposite effects on facial morphology due to gene dosage sensitivity. Hum
Genet 2014;133(9):1117-25.

27. Oliver KL, Lukic V, Thorne NP et al. Harnessing gene expression networks to prioritize candidate epileptic
encephalopathy genes. PLoS One 2014;9(7):e102079.

28. Hoischen A, Krumm N, Eichler EE. Prioritization of neurodevelopmental disease genes by discovery of new
mutations. Nat Neurosci 2014;17(6):764-72.

29. Campbell IM, Rao M, Arredondo SD et al. Fusion of large-scale genomic knowledge and frequency data
computationally prioritizes variants in epilepsy. PLoS Genet 2013;9(9):e1003797.

30. Lim JS, Kim WI, Kang HC et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading
to intractable epilepsy. Nat Med 2015;21(4):395-400.

31. Lipton JO, Sahin M. The neurology of mTOR. Neuron 2014;84(2):275-91.
32. Heinzen EL, Swoboda KJ, Hitomi Y et al. De novo mutations in ATP1A3 cause alternating hemiplegia of

childhood. Nat Genet 2012;44(9):1030-4.
33. Campeau PM, Kasperaviciute D, Lu JT et al. The genetic basis of DOORS syndrome: an exome-sequencing study.

Lancet Neurol 2014;13(1):44-58.
34. Pisano T, Spiller S, Mei D et al. Functional characterization of a novel C-terminal ATP1A2 mutation causing

hemiplegic migraine and epilepsy. Cephalalgia 2013;33(16):1302-10.
35. De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure 2013;22(10):803-

11.
36. Nobile C, Striano P. PRRT2: a major cause of infantile epilepsy and other paroxysmal disorders of childhood.

Prog Brain Res 2014;213:141-58.
37. Mignot C, Moutard ML, Trouillard O et al. STXBP1-related encephalopathy presenting as infantile spasms and

generalized tremor in three patients. Epilepsia 2011;52(10):1820-7.
38. Seltzer LE, Ma M, Ahmed S et al. Epilepsy and outcome in FOXG1-related disorders. Epilepsia 2014;55(8):1292-

300.
39. Carvill GL, Regan BM, Yendle SC et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet

2013;45(9):1073-6.
40. Lemke JR, Lal D, Reinthaler EM et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.

Nat Genet 2013;45(9):1067-72.
41. Lesca G, Rudolf G, Bruneau N et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal

epilepsies and encephalopathies with speech and language dysfunction. Nat Genet 2013;45(9):1061-6.
42. Girard JM, Turnbull J, Ramachandran N, Minassian BA. Progressive myoclonus epilepsy. Handb Clin Neurol

2013;113:1731-6.
43. Boissé Lomax L, Bayly MA, Hjalgrim H et al. ‘North Sea’ progressive myoclonus epilepsy: phenotype of subjects

with GOSR2 mutation. Brain 2013;136(Pt 4):1146-54.
44. Muona M, Berkovic SF, Dibbens LM et al. A recurrent de novo mutation in KCNC1 causes progressive myoclonus

epilepsy. Nat Genet 2015;47(1):39-46.
45. Arsov T, Mullen SA, Damiano JA et al. Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1

deficiency. Epilepsia 2012;53(12):e204-7.
46. Lebon S, Suarez P, Alija S et al. When should clinicians search for GLUT1 deficiency syndrome in childhood

generalized epilepsies? Eur J Paediatr Neurol 2015;19(2):170-5.
47. Hildebrand MS, Damiano JA, Mullen SA et al. Glucose metabolism transporters and epilepsy: only GLUT1 has

an established role. Epilepsia 2014;55(2):e18-21.
48. Muhle H, Helbig I, Frøslev TG et al. The role of SLC2A1 in early onset and childhood absence epilepsies. Epilepsy

Res 2013;105(1-2):229-33.
49. Scheffer IE, Harkin LA, Grinton BE et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B

mutations. Brain 2007;130(Pt 1):100-9.